Armistice Capital, LLC Pro Mis Neurosciences Inc. Transaction History
Armistice Capital, LLC
- $6.51 Billion
- Q3 2025
A detailed history of Armistice Capital, LLC transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,974,518 shares of PMN stock, worth $1.16 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,974,518
Previous 2,137,896
39.13%
Holding current value
$1.16 Million
Previous $1.03 Million
21.73%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding PMN
# of Institutions
25Shares Held
10MCall Options Held
0Put Options Held
0-
Ally Bridge Group (Ny) LLC New York, NY6.23MShares$2.43 Million2.7% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3295KShares$115,1220.03% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il170KShares$66,3300.0% of portfolio
-
Hrt Financial LP New York, NY68.1KShares$26,5420.0% of portfolio
-
Xtx Topco LTD London, X067.7KShares$26,3970.0% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...